investigation
Last reviewed 10/2023
Investigation in PMR is used to support the diagnosis as well as to rule out any other possible causes. BSR guidelines recommends the following investigations in polymyalgia rheumatica:
- ESR
- usually raised and returns to normal with treatment
- in some patients low or normal rates have been reported as well
- CRP
- more sensitive marker
- usually elevated (1)
- full blood count - reveals a normochromic, normocytic anaemia in many cases (2)
- investigations which should be carried out to exclude other conditions before starting steroid treatment include
- rheumatoid factor (and anti-citrullinated peptide antibody if available) - negative
- liver function
- urea and electrolytes (1)
- myeloma screen including protein electrophoresis and examination of urine for Bence Jones protein
- thyroid stimulating hormone
- calcium, alkaline phosphatase
- creatine kinase
- dipstick urinalysis
- chest radiograph e.g., if prominent systemic symptoms
- ANA (1)
Reference:
- (1) Dasgupta B et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford). 2010;49(1):186-90.
- (2) Mackie SL, Mallen CD. Polymyalgia rheumatica. BMJ. 2013;347:f6937.
- (3) Dasgupta B, et al. Management guidelines and outcome measures in polymyalgia rheumatica (PMR). Clin Exp Rheumatol 2007;25(Suppl.47):s130-s136